Predictor Biomarkers of Nonelective Hospital Readmission and Mortality in Malnourished Hospitalized Older Adults - 21/11/24

Doi : 10.14283/jfa.2020.10 
Karol M. Pencina 1, , S. Bhasin 1, M. Luo 2, G.E. Baggs 2, S.L. Pereira 2, G.J. Davis 3, N.E. Deutz 4, T.G. Travison 5
1 Research Program in Men’s Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women’s Hospital, Harvard Medical School, 221 Longwood Avenue, 02115, Boston, MA, USA 
2 Abbott Nutrition Division, Research and Development, 3300 Stelzer Road, Columbus, OH, USA 
3 Abbott Diagnostic Division, Oncology Diagnostics & Immunoassay Development R&D, 100 Abbott Park Road, Abbott Park, IL, USA 
4 Center for Translational Research in Aging and Longevity, Department of Health and Kinesiology, Texas A & M University, College Station, TX, USA 
5 Institute for Aging Research, Hebrew SeniorLife, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA 

a kpencina@bhw.harvard.edu kpencina@bhw.harvard.edu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

90-day mortality and rehospitalizations are important hospital quality metrics. Biomarkers that predict these outcomes among malnourished hospitalized patients could identify those at risk and help direct care plans.

Objectives

To identify biomarkers that predict 90-day (primary) and 30-day (secondary) mortality or nonelective rehospitalization.

Design and Participants

An analysis of the ability of biomarkers to predict 90- and 30-day mortality and rehospitalization among malnourished hospitalized patients.

Setting

52 blood biomarkers were measured in 193 participants in NOURISH, a randomized trial that determined the effects of a nutritional supplement on 90-day readmission and death in patients >65 years. Composite outcomes were defined as readmission or death over 90-days or 30-days. Univariate Cox Proportional Hazards models were used to select best predictors of outcomes. Markers with the strongest association were included in multivariate stepwise regression. Final model of hospital readmission or death was derived using stepwise selection.

Measurements

Nutritional, inflammatory, hormonal and muscle biomarkers.

Results

Mean age was 76 years, 51% were men. In univariate models, 10 biomarkers were significantly associated with 90-day outcomes and 4 biomarkers with 30-day outcomes. In multivariate stepwise selection, glutamate, hydroxyproline, tau-methylhistidine levels, and sex were associated with death and readmission within 90-days. In stepwise selection, age-adjusted model that included sex and these 3 amino-acids demonstrated moderate discriminating ability over 90-days (C-statistic 0.68 (95%CI 0.61, 0.75); age-adjusted model that included sex, hydroxyproline and Charlson Comorbidity Index was predictive of 30-day outcomes (C-statistic 0.76 (95%CI 0.68, 0.85).

Conclusions

Baseline glutamate, hydroxyproline, and tau-methylhistidine levels, along with sex and age, predict risk of 90-day mortality and nonelective readmission in malnourished hospitalized older patients. This biomarker set should be further validated in prospective studies and could be useful in prognostication of malnourished hospitalized patients and guiding in-hospital care.

Le texte complet de cet article est disponible en PDF.

Key words : Biomarkers, 90-day readmission, 30-day readmission, nutritional biomarkers of mortality and readmission, mortality in hospitalized patients


Plan


 Electronic Supplementary Material
Supplementary material is available for this article at jfa.2020.10 and is accessible for authorized users.


© 2020  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 9 - N° 4

P. 226-231 - octobre 2020 Retour au numéro
Article précédent Article précédent
  • The Validity of the Sunfrail Tool: A Cross-Sectional Study Among Dutch Community-Dwelling Older People
  • Robbert J.J. Gobbens, M. Maggio, Y. Longobucco, M. Barbolini
| Article suivant Article suivant
  • Predictive Factors of In-Hospital Mortality in Older Adults with Community-Acquired Bloodstream Infection
  • Davide Angioni, M. Hites, F. Jacobs, S. De Breucker

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.